Standard of care treatment
Standard of care treatment is a pharmaceutical drug with 40 clinical trials. Currently 13 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
11
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.0%
12 of 20 finished
40.0%
8 ended early
13
trials recruiting
40
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Nipocalimab in Moderate to Severe Sjogren's Disease
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Clinical Trials (40)
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Nipocalimab in Moderate to Severe Sjogren's Disease
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)
Personalized Evaluation of Susptected Myocardial Ischemia
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's Disease
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
SportsPro: Post-Market Clinical Follow Up Study
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC
Developing Strategies for Effective Debridement in Patients for Venous Leg Ulcers
Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders
Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD
Effect of Acute Cardiovascular Disease on Microbiome
Antibiotic Selection Using Next Generation Sequencing vs Urine Culture
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 40